tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Catanzaro, 254 are a BUY (77.44%), 74 are a HOLD (22.56%).
Analyst Joseph Catanzaro, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 45.28% that have a potential upside of 43.43% achieved within 163 days.
Joseph Catanzaro’s has documented 661 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on TNGX, Tango Therapeutics at 11-Mar-2026.
Analyst best performing recommendations are on CTMX (CYTOMX THERAPEUTICS).
The best stock recommendation documented was for CTMX (CYTOMX THERAPEUTICS) at 4/14/2025. The price target of $2.5 was fulfilled within 29 days with a profit of $1.89 (309.84%) receiving and performance score of 106.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 27-Aug-2024
$1.75
$-0.27 (-13.37%)
$5
1 years 6 months 25 days ago
(27-Aug-2024)
1/6 (16.67%)
$0.07 (4.17%)
2
Hold Since 15-Dec-2023
1 years 7 months 3 days ago
(21-Aug-2024)
0/4 (0%)
$31.56 (191.97%)
Hold Since 21-Aug-2024
$1.5
$-0.52 (-25.74%)
1 years 7 months 3 days ago
(21-Aug-2024)
0/2 (0%)
$-0.05 (-3.23%)
Buy Since 18-Apr-2018
3 years 11 months 13 days ago
(11-Apr-2022)
0/1 (0%)
$93 (163.16%)
Buy Since 30-Aug-2021
3 years 11 months 13 days ago
(11-Apr-2022)
2/2 (100%)
$4.5 (25.00%)
82
Which stock is Joseph Catanzaro is most bullish on?
Which stock is Joseph Catanzaro is most reserved on?
What Year was the first public recommendation made by Joseph Catanzaro?
